Sihuan Biotech announced that the company plans to acquire 80% of the shares of Jilin Changyuan Pharmaceutical Co., Ltd. held by Jiangxi Jixin Biotechnology Co., Ltd. in cash, at a provisional transfer price of 160 million yuan. The company held a board of directors meeting on August 17, 2026 to review and pass the relevant bill and sign an agreement on the intention to transfer shares. The deal is still in the planning stage, and further negotiations are needed on whether to sign a formal acquisition agreement based on the results of due diligence, audit and evaluation. There is still uncertainty about whether the final deal can be reached.

Sihuan Biotech announced that the company plans to acquire 80% of the shares of Jilin Changyuan Pharmaceutical Co., Ltd. held by Jiangxi Jixin Biotechnology Co., Ltd. in cash, at a provisional transfer price of 160 million yuan. The company held a board of directors meeting on August 17, 2026 to review and pass the relevant bill and sign an agreement on the intention to transfer shares. The deal is still in the planning stage, and further negotiations are needed on whether to sign a formal acquisition agreement based on the results of due diligence, audit and evaluation. There is still uncertainty about whether the final deal can be reached.